Arrowhead Pharmaceuticals, Inc. (ARWR) vs Spyre Therapeutics, Inc. (SYRE)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Spyre Therapeutics, Inc. SYRE 79.90 −0.25%
Arrowhead Pharmaceuticals, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. is the larger, with a market value of $8.3B against $7.4B — 1.1× the size. Arrowhead Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 16.1% against −81.8%. Spyre Therapeutics, Inc. has the higher net margin (0.00% vs −47.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 8 and Spyre Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | ARWR | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (33.82%) | 0.00% | 0.00% |
| Net margin | (47.79%) | 0.00% | 0.00% |
| Free cash flow margin | (11.22%) | 0.00% | 0.00% |
| Return on equity | (64.91%) | (28.52%) | (56.36%) |
| Return on assets | (18.32%) | (20.90%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack